India will make 8 million doses of Johnson & Johnson’s Covid-19 vaccine available by the end of October under the Quad partnership, Foreign Secretary Harsh Vardhan Shringla said.
Prime Minister Narendra Modi informed fellow leaders of the Quad grouping—made up also of the U.S., Australia and Japan—at their summit in Washington, Shringla said. The Quad countries will pay for the vaccine and India will bear a certain share of the cost, he said.
“This would be ready by the end of October. It would be compatible with our decision to resume vaccine export,” Shringla told reporters. “This will be an immediate delivery from the Quad in the Indo-Pacific region.”
India earlier said it will resume exports of Covid-19 vaccines for the World Health Organization’s Covax initiative from October. Home to the world’s largest vaccine-manufacturing industry, India deferred exports in early April after a surge in delta variant infections began to sweep through the country.
The Quad countries have promised to donate 1.2 billion doses of vaccines globally. Johnson and Johnson is collaborating with India’s Biological E to manufacture the vaccines.
France will decide over the coming days on possible actions if its fishermen don’t get access to U.K. waters in accordance with the Brexit deal.View Article
A forecast for a developing drought in the U.S. southern Plains is the latest threat to dwindling world wheat supplies.View Article
High tax burden and scapegoating leave executives in the cold, but Johnson’s business backers see little political alternative.View Article
The European Union could weigh terminating the post-Brexit trade deal if the U.K. government pulls out of its commitments over Northern Ireland, according to people familiar with the matter.View Article
NTPC Ltd., India’s top power producer, is seeking to import coal for the first time in two years, underscoring worries about shortages even as a supply crunch slowly begins to…View Article
Industry updates and weekly newsletter direct to your inbox!